Metrogel-vaginal
Drug - Metrogel-vaginal
The trade name of the product as shown on the labeling.
Dosage -
GEL; VAGINAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Metronidazole
Multiple ingredients are in alphabetical order.
Strength -
0.75%
The potency of the active ingredient(s), Metronidazole. May repeat for multiple part products.
Applicant -
3M
The firm name holding legal responsibility for Metrogel-vaginal. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
020208
The FDA assigned number to Metrogel-vaginal. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Metrogel-vaginal. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
BX
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Aug 17, 1992
The date Metrogel-vaginal was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
Yes
The pioneer or innovator of Metrogel-vaginal. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Metrogel-vaginal is in. Format is RX, OTC, DISCN.
Applicant Full Name -
3m Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Metrogel-vaginal.
Metrogel-vaginal
|